RegistryNewsletter
0
2019.2
$205,000
67
% Disbursed
Signed & active

DR. RUMBAUGH

Purpose: To test the hypothesis that the pathogenicity of distinct SYNGAP1 variants found in patients will correlate with the extent of dysfunction in neurons derived from their own cells.

Funding: $205,500 over three years to support the training of a postdoctoral researcher.

Key people: Gavin Rumbaugh, Ph.D. & Nerea Llamosas PhD

Status: Approved, Signed, 67% disbursed.


© Copyright  2019-2020 Syngap Research Fund  | All Rights Reserved | 
Privacy Policy
0